These mechanisms are not mutually exclusive and likely act synergistically to produce LDNs therapeutic effects
Increased type 2 innate lymphoid cells in patients with drug reaction with eosinophilia and systemic symptoms syndrome
Observed responses in research settings are generally mild and may include temporary administration-site irritation, redness, warmth sensations, local sensitivity, temporary itching, mild fatigue, or response variability depending on research amount, administration frequency, protocol duration, and individual sensitivity
Final Thoughts: Nutrition Can Help, But Not Replace Peptide Therapies Injectable peptides like PT-141 and BPC-157 offer fast, targeted results
Together, they address multiple healing pathways simultaneously, often producing faster and more complete recovery than single-peptide protocols